Use of PLA.sub.2 inhibitors as treatment for alzheimer's disease
US5478857A · kind A · utility
38Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 1993 |
| Grant date | Dec 26, 1995 |
| Priority date | — |
| Expiry date | Dec 23, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides methods for the treatment or prevention of Alzheimer's disease in a mammal which comprises administering to a mammal in need thereof an effective amount of an inhibitor of phospholipase A.sub.2. This invention also provides a series of compounds which are useful as inhibitors of phospholipases A.sub.2, especially cytosolic phospholipase A.sub.2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.